Snoezelen multisensory relaxation to reduce anxiety during pediatric chemotherapy hospital stays

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This monocentric proof-of-concept study uses a within-subject design to compare anxiety and related symptoms during a chemotherapy hospitalization without Snoezelen to a subsequent hospitalization with Snoezelen sessions. Participants aged 8–17 at Centre Oscar Lambret will complete self-report questionnaires (GAD-7, SCARED, CDI, PedsQL, BARF), provide data on anxiolytic/antiemetic use and vomiting, and take part in a semi-structured interview. During the second hospitalization patients receive 45-minute Snoezelen sessions every two days and researchers will combine quantitative pre-post comparisons with qualitative interview analysis. The mixed-methods approach is intended to explore effects on anxiety, mood, quality of life, and chemotherapy-related nausea.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* New patient
* Treated in the Paediatrics/AJA department of the Oscar Lambret Centre for cancer (all types of cancer)
* Hospitalisation for several days
* Highly emetogenic chemotherapy treatment: this corresponds to all in-patient treatments carried out in the Paediatrics/AJA department.
* Age at diagnosis : ≥ 8 years and \< 18 years.
* French language
* Information for the patient and those with parental authority; consent signed by the patient and those with parental authority.
* Valid social security cover

Exclusion Criteria:

* Contraindication to SNOEZELEN:

  * Claustrophobia
  * Presence of psychiatric, addictive or cognitive disorders that would prevent compliance with the protocol requirements;
* State of health not allowing participation in the study (severe fatigue, symptoms refractory to treatment).
* Pregnant or breast-feeding women

Where it's running

• Centre Oscar Lambret
  Lille, France Recruiting

Study contacts

• Study coordinator: Fanny BEN OUNE
• Email: promotion@o-lambret.fr
• Phone: +33320295918

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• FaceSay: a computer program to help kids recognize facial expressions and improve social interactions

  A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.

  Recruiting Children's Hospital of Philadelphia · Philadelphia, Pennsylvania · NCT07923370

• Access to Innovative Cancer Treatments for Children and Young People in Belgium

  This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Antwerp and 5 other locations · NCT07727694

• BCB-276 CAR T therapy for DIPG in children and young adults

  This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.

  Recruiting at 3 sites Phase 2 BrainChild Bio, Inc · Los Angeles, California and 5 other locations · NCT07680439

• CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes

  This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.

  Recruiting Resonance, Inc. · Yerevan and 5 other locations · NCT07632014

• Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children

  This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.

  Recruiting TC Erciyes University · Kayseri · NCT07537062

• Laser thermal therapy for young people with low-grade glioma

  This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07506239

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.